These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25719301)

  • 1. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature.
    Ökdemir D; Hatipoğlu N; Akar HH; Gül Ü; Akın L; Tahan F; Kurtoğlu S
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):923-5. PubMed ID: 25719301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Systemic Hypersensitivity Reactions to Gonadotropin-Releasing Hormone Analogues during Treatment of Central Precocious Puberty.
    Kirkgoz T; Karakoc-Aydiner E; Bugrul F; Yavas Abali Z; Helvacioglu D; Kiykim A; Bilgic Eltan S; Aruci Kasap N; Baris S; Ozen A; Guran T; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(1):66-72. PubMed ID: 31972562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening anaphylaxis to leuprorelin acetate depot: case report and review of the literature.
    Fujisaki A; Kondo Y; Goto K; Morita T
    Int J Urol; 2012 Jan; 19(1):81-4. PubMed ID: 22050405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature.
    Lam C; Tjon J; Hamilton J; Ahmet AH
    Pharmacotherapy; 2006 Dec; 26(12):1811-5. PubMed ID: 17125443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudotumour Cerebri Presentation in a Child Under the Gonadotropin-Releasing Hormone Agonist Treatment.
    Gül Ü; Kaçar Bayram A; Kendirci M; Hatipoğlu N; Okdemir D; Gümüş H; Kurtoğlu S
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):365-7. PubMed ID: 27087351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis.
    Lüchinger AB; Mijatovic V; Rustemeyer T; Hompes PG
    Am J Med Sci; 2011 Mar; 341(3):240-2. PubMed ID: 21233692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.
    Shore ND; Sieber P; Schimke L; Perzin A; Olsen S
    Urol Nurs; 2013; 33(5):236-44, 248. PubMed ID: 24354113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty.
    Akın O; Yavuz ST; Hacıhamdioğlu B; Sarı E; Gürsel O; Yeşilkaya E
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1387-9. PubMed ID: 26197466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair loss in children on long-acting gonadotropin-releasing hormone agonist triptorelin treatment.
    Kauschansky A; Lurie R; Ingber A
    Acta Derm Venereol; 1997 Jul; 77(4):333. PubMed ID: 9228240
    [No Abstract]   [Full Text] [Related]  

  • 12. A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.
    Zenaty D; Blumberg J; Liyanage N; Jacqz-Aigrain E; Lahlou N; Carel JC;
    Horm Res Paediatr; 2016; 86(3):188-195. PubMed ID: 27603324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty.
    Lee PA; Klein K; Mauras N; Lev-Vaisler T; Bacher P
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3153-9. PubMed ID: 24926950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine adenocarcinoma after GnRH agonist treatment.
    Dessole S; Ruiu GA; Cherchi PL; Ambrosini G
    Arch Gynecol Obstet; 2000 Feb; 263(3):148-9. PubMed ID: 10763848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptorelin (Triptodur) for central precocious puberty.
    Med Lett Drugs Ther; 2018 Jan; 60(1537):7-8. PubMed ID: 29294465
    [No Abstract]   [Full Text] [Related]  

  • 16. Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.
    Bertelloni S; Mucaria C; Baroncelli GI; Peroni D
    Expert Rev Clin Pharmacol; 2018 Jul; 11(7):659-667. PubMed ID: 29957076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
    Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty.
    Klein K; Yang J; Aisenberg J; Wright N; Kaplowitz P; Lahlou N; Linares J; Lundström E; Purcea D; Cassorla F
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1241-1248. PubMed ID: 26887034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.